One-Stop R&D Shopping? Celgene To Seed, Help Fund And Maybe Buy Out New Oncology/Fibrosis Biotech
This article was originally published in The Pink Sheet Daily
Executive Summary
PharmAria, the brainchild of three former Amira execs, debuted publicly on Oct. 15. Celgene will participate in the Series A financing and have an option for a buyout.